Global Safety Syringes Market

Safety Syringes Market Size, Share, Growth Analysis, By Product(Retractable Safety Syringes and Non-Retractable Safety Syringes), By Type(Attached Needle and Detachable Needles), By End-user(Hospitals, Blood Donation Camps, and Others), By Therapy(Insulin and Tuberculosis), By Region - Industry Forecast 2024-2031


Report ID: SQMIG35B2132 | Region: Global | Published Date: March, 2024
Pages: 202 | Tables: 111 | Figures: 77

Safety Syringes Market News

  • In February 2024, Sharps Technology, Inc., an innovative medical device and pharmaceutical packaging company offering patented, best-in-class syringe products, made the first shipment of its 1mL and 3mL Securegard smart safety syringe line to the Latin American healthcare market.

     

  • In January 2024, Sharps Technology, Inc. and Roncadelle Operations, a driving force in the development of novel medical drug delivery devices with its seasoned team boasting over two decades of healthcare expertise, signed a Letter of Intent (LOI) to enter into a sales and marketing agreement which would enable the Company and Roncadelle to cooperatively sell and distribute each other’s products to their respective areas of influence and expand Sharps’ American-based product market into Europe, the Middle East, Africa, and the Asia-Pacific region.

     

  • In January 2023, MTD Group obtained FDA clearance by its affiliate Pikdare S.p.A. for DropSafe Sicura passive safety needle for the intramuscular and subcutaneous injection of vaccines and other drugs.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Safety Syringes Market size was valued at USD 8.45 billion in 2022 and is poised to grow from USD 9.11 billion in 2023 to USD 16.61 billion by 2031, growing at a CAGR of 7.8% in the forecast period (2024-2031).

The safety syringes market exhibits a competitive landscape characterized by the presence of several key players striving for market dominance. Companies such as Becton, Dickinson and Company, Medtronic plc, Terumo Corporation, Smiths Medical, and Retractable Technologies, Inc. are at the forefront of innovation and product development in this sector. 'Becton, Dickinson and Company (US)', 'Medtronic plc (US)', 'Terumo Corporation (Japan)', 'Smiths Medical (US)', 'Retractable Technologies, Inc. (US)', 'Gerresheimer AG (Germany)', 'Baxter International Inc. (US)', 'B. Braun Melsungen AG (Germany)', 'Cardinal Health, Inc. (US)', 'Nipro Corporation (Japan)', 'UltiMed, Inc. (US)', 'Revolutions Medical Corporation (US)', 'Axel Bio Corporation (US)', 'Gerresheimer AG (Germany)', 'HTL-STREFA S.A. (Poland)', 'DMC Medical Limited (UK)', 'Sol-Millennium Medical Group (South Korea)', 'Amcor plc (UK)', 'Bayer AG (Germany)', 'Vygon (France)'

Accidental needlestick injuries in healthcare settings carry a substantial threat to healthcare providers, potentially resulting in the transmission of bloodborne illnesses like HIV, hepatitis B, and hepatitis C. This increased recognition of the dangers associated with needlestick injuries has spurred a notable surge in the market for safety syringes. These specialized syringes are designed to effectively mitigate the risk of unintended needlestick injuries and their subsequent consequences.

Rise of Self-Injection and Home Healthcare: Patients are increasingly taking an active role in managing their conditions, and safety syringes equipped with user-friendly features are enabling safer and more convenient self-administration of medications at home. This trend aligns with the growing emphasis on patient empowerment, reducing healthcare facility visits, and improving overall treatment adherence.

North America currently stands as the dominating market in the safety syringes industry. The region's dominance can be attributed to stringent regulations regarding healthcare worker safety, well-established healthcare infrastructure, and higher awareness levels about the risks associated with needlestick injuries and bloodborne infections. Additionally, increased investments in research and development, along with a proactive approach to adopting advanced medical technologies, have further fueled the adoption of safety syringes.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Safety Syringes Market

Report ID: SQMIG35B2132

$5,300
BUY NOW GET FREE SAMPLE